GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Voluntis SA (XPAR:ALVTX) » Definitions » Gross-Profit-to-Asset %

Voluntis (XPAR:ALVTX) Gross-Profit-to-Asset % : 14.83% (As of Jun. 2021)


View and export this data going back to 2018. Start your Free Trial

What is Voluntis Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Voluntis's annualized Gross Profit for the quarter that ended in Jun. 2021 was €2.57 Mil. Voluntis's average Total Assets over the quarter that ended in Jun. 2021 was €17.30 Mil. Therefore, Voluntis's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2021 was 14.83%.


Voluntis Gross-Profit-to-Asset % Historical Data

The historical data trend for Voluntis's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voluntis Gross-Profit-to-Asset % Chart

Voluntis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20
Gross-Profit-to-Asset %
70.41 49.79 17.67 10.19 23.62

Voluntis Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.81 10.73 22.48 31.78 14.83

Competitive Comparison of Voluntis's Gross-Profit-to-Asset %

For the Health Information Services subindustry, Voluntis's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Voluntis's Gross-Profit-to-Asset % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Voluntis's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Voluntis's Gross-Profit-to-Asset % falls into.



Voluntis Gross-Profit-to-Asset % Calculation

Voluntis's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2020 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2020 )/( (Total Assets (A: Dec. 2019 )+Total Assets (A: Dec. 2020 ))/ count )
=4.149/( (17.276+17.852)/ 2 )
=4.149/17.564
=23.62 %

Voluntis's annualized Gross-Profit-to-Asset % for the quarter that ended in Jun. 2021 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Jun. 2021 )/( (Total Assets (Q: Dec. 2020 )+Total Assets (Q: Jun. 2021 ))/ count )
=2.566/( (17.852+16.753)/ 2 )
=2.566/17.3025
=14.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Jun. 2021) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Voluntis Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Voluntis's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Voluntis (XPAR:ALVTX) Business Description

Traded in Other Exchanges
N/A
Address
58, Avenue de Wagram, Paris, FRA, 75017
Voluntis SA is engaged in developing patient-centric digital health solutions. The company offers digital solutions for diabetes, respiratory diseases, cancer, anticoagulation treatments, and haemophilia. The Company operates in a single segment: Development of therapeutic digital solutions based on its Theraxium platform.

Voluntis (XPAR:ALVTX) Headlines

No Headlines